Pulmatrix Inc is is a clinical stage biotechnology company. The Company is engaged in discovery and development of a novel class of inhaled therapeutic products intended to prevent and treat respiratory diseases and infections.
$1.29
As of 04/09/2021 IEX book CBOE book
2021 © Stock Market MBA, Inc.